Share This

Hot News

默沙東估新冠口服藥Molnupiravir明年底前可銷70億美元 @ 2021-10-29T08: Back Hot News
Keyword:默沙東 學名藥 新冠口服藥
Concept:默沙東授權生產新冠口服藥學名藥
默沙東抗疫口服藥授權生產學名藥 可望造福窮國
默沙東授權生產「新冠口服藥」學名藥,可望造福中低收入國家
另外,默沙東周三表示,將跟聯合國支持的非牟利組織「藥品專利聯盟」(MPP)簽署授權協議,將允許更多公司制造學名藥版本的MOLNUPIRAVIR,可望協助受疫情肆虐的窮國取得新冠口服藥。
默沙東抗疫口服藥授權生產學名藥 可望造福窮國
默沙東授權生產口服藥學名藥 中低收入國家將受惠

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.